Puhua Capital — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Bit Biobit.bio in 𝕏Nov 2021

bit.bio is a synthetic biology company that engineers human induced pluripotent stem cells into defined cell types for research, drug discovery, and cell therapy applications.

BiotechDeep TechHealthtechMedical Devices

Dr Mark Kotter(Founder)Przemek Obloj(CEO)in Emma Pepperell inMark Kotter(Founder)

Co-investorsForesite Capital BlueYard Capital ARCH Venture Partners Dynamk Capital Good AI Capital Harmonix Fund +7 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.